LA
TLSIW icon

Linden Advisors’s TriSalus Life Sciences Warrant TLSIW Stock Holding History

Linden Advisors’s Portfolio TLSIW Stock Details TLSIW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-246,601
Closed -$132K – 751
2021
Q4 		$132K Hold
246,601
– – ﹤0.01% 692
2021
Q3 		$205K Hold
246,601
– – ﹤0.01% 577
2021
Q2 		$248K Buy
246,601
+3,000
+1% +$2.96K ﹤0.01% 650
2021
Q1 		$286K Buy
+243,601
New +$440K ﹤0.01% 628

Other funds holding TLSIW

MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
AGC
Angelo Gordon & Co New York $1.06B AUM 47.95% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
IM
Islet Management New York $49.1M AUM 17.59% 1-Year Est. Return
SCC
Spring Creek Capital Wichita, Kansas $2.53B AUM 19.59% 1-Year Est. Return
VI
Vestcor Inc Fredericton, New Brunswick, Canada $3.63B AUM 21.49% 1-Year Est. Return
KC
Kepos Capital New York $61.3M AUM 12.13% 1-Year Est. Return

Linden Advisors's TLSIW Position: Q1 2022 in Review

Linden Advisors sold out of TriSalus Life Sciences Warrant (TLSIW) in Q1 2022, closing a stake of 246,601 shares — an estimated $132K sold.

Linden Advisors first reported a position in TLSIW in Q1 2021 and held it in 4 quarters. The position peaked at $286K in Q1 2021. 26 funds tracked by Wall St. Rank hold TLSIW as of Q1 2022.

  • Linden Advisors reported no remaining TriSalus Life Sciences Warrant position as of Q1 2022 after selling out during the quarter.
  • Linden Advisors sold 246,601 TriSalus Life Sciences Warrant shares in Q1 2022, an estimated $132K.
  • Linden Advisors first reported a position in TriSalus Life Sciences Warrant in Q1 2021 and held it in 4 quarters.
  • Linden Advisors's TriSalus Life Sciences Warrant position peaked at $286K in Q1 2021.
  • 26 funds tracked by Wall St. Rank held TriSalus Life Sciences Warrant as of Q1 2022.

Based on Linden Advisors's 13F filing for Q1 2022, filed 16 May 2022.